Receptor.AI provides an AI-powered drug discovery platform for pharma, biotech and academia that covers the whole drug discovery pipeline in a flexible and scalable manner. Our AI solutions are tailored to discover novel drug candidates for the most challenging diseases with high success rates in clinical trials.

Receptor.AI’s mission is to create superior drugs, which are safe, efficient and successful in clinical trials by developing a next generation drug discovery platform based on the synergy of AI, computational chemistry and biomimetic technologies, such as organs-on-a-chip.

We dream about a world where new drugs are developed so fast, that new diseases have no chances to spread. We envision a radical minimisation of drug testing on animals and humans with improvement of their safety and efficiency by combining advanced AI with novel organ-on-a-chip technologies.